IADR Abstract Archives

Ameloblastin Induces Tumor Suppression and Chemosensitivity in Osteosarcoma

Objectives: Ameloblastin (AMBN), the most abundant non-amelogenin enamel matrix protein, has a role in enamel matrix mineralization and ameloblast differentiation. Recently, it was reported that AMBN was expressed in bone tissue and we clarified that AMBN induced osteogenic differentiation through AMBN-CD63-Integrinβ1-Src axis by using osteosarcoma (OS) cell lines. OS affects jaw or long bones and doxorubicin is commonly used for the treatment. However, it still shows a poor prognosis with pulmonary metastasis. Here, we made a hypothesis that AMBN possess tumor suppressive role and enhances chemosensitivity to doxorubicin treatment in OS.
Methods: Tissue samples of 37 OS cases retrieved from Hiroshima University Hospital were used for correlating immunoexpression of AMBN and prognosis of patients. In vivo experiments, 143B-Luc cells were injected into five-week-old male BALB/cAnNCrlCrlj mice, and tumor growth and metastasis were analyzed by bioluminescent imaging. In vitro experiments, western blot, wound healing assay, soft-agar colony formation assay, and FACS analysis were used.
Results: (1) In immunohistochemical analysis of 37 clinical OS cases, AMBN expression showed lower frequency of pulmonary metastasis (chi-square test, P<0.05) and better prognosis. (2) In vivo, AMBN stable 143B-Luc cells showed the inhibition of tumor growth and pulmonary metastasis by using mouse xenograft model (t-test, P<0.05). (3) In vitro, AMBN stable 143B-Luc cells showed apoptosis with the cleavage of caspase-3, chemosensitivity to doxorubicin and suppressed colony formation ability, migration via the inactivation of Src-Stat3 pathway. Moreover, these phenotypes were rescued by the induction of constitutive active Src (t-test, P<0.05).
Conclusions: We demonstrate that AMBN has a novel tumor suppressive role and induce chemosensitivity to doxorubicin via Src-Stat3 inactivation in OS. Our findings indicate that AMBN has a potential to be used as a therapeutic target of OS. (This study was supported by JSPS.)
Division: IADR/AADR/CADR General Session
Meeting: 2015 IADR/AADR/CADR General Session (Boston, Massachusetts)
Location: Boston, Massachusetts
Year: 2015
Final Presentation ID: 3110
Abstract Category|Abstract Category(s): Oral Medicine & Pathology
Authors
  • Ando, Toshinori  ( Hiroshima university , Hiroshima , Japan )
  • Tsunematsu, Takaaki  ( University of Tokushima Graduate School , Tokushima , Japan )
  • Kudo, Yasusei  ( University of Tokushima Graduate School , Tokushima , Japan )
  • Ogawa, Ikuko  ( Hiroshima university , Hiroshima , Japan )
  • Miyauchi, Mutsumi  ( Hiroshima university , Hiroshima , Japan )
  • Takata, Takashi  ( Hiroshima university , Hiroshima , Japan )
  • Support Funding Agency/Grant Number: Japan society for the promotion of science
    Financial Interest Disclosure: NONE
    SESSION INFORMATION
    Poster Session
    Oral Pathology
    Friday, 03/13/2015 , 03:30PM - 04:45PM